Bausch Health Companies Q2 2024 GAAP EPS $0.03 May Not Be Comparable To $0.28 Estimate, Sales $2.403B Beat $2.339B Estimate
Portfolio Pulse from Benzinga Newsdesk
Bausch Health Companies reported Q2 2024 GAAP EPS of $0.03, which may not be comparable to the $0.28 estimate. However, the company reported sales of $2.403 billion, beating the $2.339 billion estimate.
August 01, 2024 | 11:18 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bausch Health Companies reported mixed Q2 2024 results with GAAP EPS of $0.03, which may not be comparable to the $0.28 estimate, but sales of $2.403 billion beat the $2.339 billion estimate.
The mixed results, with EPS potentially not comparable to estimates but sales beating expectations, create a neutral short-term impact. Investors may be cautious due to the EPS discrepancy but reassured by the strong sales performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100